Company Announcements

BioMérieux 2014 Industrial Applications revenue declined 0.9%, up 0.8% on a like-for-like basis, to €327 million ($436 million) to represent 19% of sales. Sales for Industrial Applications rose in all regions except China. R&D-related revenue was flat at €7 million ($9 million).

GE Healthcare announced on its quarterly conference call that 2014 Life Science earnings grew 15%. For the fourth quarter 2014, Life Science orders rose 13%, with bioprocess orders up 60%. Quarterly Life Science revenues rose 9%, 6% organically.

In January, DANI Instruments named Tegent Scientific as its exclusive distributor for China and Vietnam.

Waters inaugurated the 400 ft2 Joint Open Laboratory established with the Chinese Pharmacopeia Commission. The two parties will jointly operate the Laboratory.

QIAGEN named Thierry Bernard as senior vice president, Molecular Diagnostics Business, in February. Most recently, he served as corporate vice president, Global Commercial Operations, Investor Relations and the Greater China Region, at bioMérieux. QIAGEN also named James E. Bradner, MD, as a member of the Supervisory Board, effective January. He is associate director of the Center for the Science of Therapeutics at the Broad Institute.

Process and Analytical Instrumentation sales represented 69% of AMETEK Electronic Instruments Group 2014 sales of $241.6 million.

In 2014, MKS Instruments Analytical Solutions Group revenue rose 8.6% to $61.2 million. The Group’s gross profit declined 2.0% to $50.3 million.

Teledyne Technologies 2014 Environmental Instrumentation revenue rose 8.0% to $268.4 million, or 24% of Instrumentation Sales.

In February, Fluidigm announced that Sweden’s Science for Life Laboratory (SciLifeLab) established the Swedish National Center for Single-Cell Biology, featuring six C1 systems, three CyTOF 2 systems and a Biomark HD system.

Endress+Hauser 2014 sales rose approximately 11% to more than €2 billion ($3 billion). Organic sales growth was just under 6%.

Xylem 2014 Test revenues rose 5.7% to $315 million to make up 13% of Water Infrastructure sales due to increased US government spending, new products and cross selling of European technologies. In the fourth quarter 2014, Test revenue grew more than 5% organically.

FLIR 2014 Detection revenue fell 5.0% to $85.7 million to make up 6% of company sales due to reduced deliveries to US customers.

PerkinElmer named Sylvie Grégoire, Pharm. D., to its Board in February. She is currently a Board member of Galenica.

Diploma named Andrew Smith as a director in February. He serves as managing director, Severn Trent Business Services.